A retrospective study on differences in neuroborreliosis symptoms, signs and findings between adults and children

Read full text
Authors: Anne Nieminen, Samuel Söderqvist, Jussi Jero, Jarmo Oksi
Cited by: 0
References: 59

Abstract

OBJECTIVES: Lyme neuroborreliosis (LNB) presents with a broad range of symptoms and its incidence is increasing in Finland. This study examines clinical differences in LNB between adults and children (< 16 years), emphasizing head and neck symptoms, the prognostic value of laboratory tests, the findings in brain MRI, and the impact of glucocorticoids on facial palsy (FP) recovery. METHODS: A retrospective analysis of LNB cases at Turku University Hospital (2011–2018) confirmed by intrathecal antibody production against Borrelia was conducted. With regard to cerebrospinal fluid pleocytosis, LNB was further classified as definite or possible. Patient characteristics were compared using appropriate statistical tests. RESULTS: In total 159 adult and 25 child LNB patients were found. The most common symptom in adults was radiculitis (37% vs. 8%, p = 0.03), while in children, it was FP (76% vs. 46%, p = 0.0052). In children, the absence of FP was linked to delayed diagnosis (5.5 ± 9.1 weeks vs. 0.97 ± 0.92 weeks p = 0.043). Of the pediatric LNB patients, 68% were seropositive for antibodies against Borrelia based on serum samples. Cranial nerve enhancement was observed in 26% of brain MRIs in the study cohort. No link between CSF findings or corticosteroid treatment and persisting FP was found. CONCLUSIONS: In adults, the most common manifestation related to LNB was radiculitis, whereas in children it was FP. One third of the pediatric patients were seronegative for antibodies against Borrelia, emphasizing the importance of CSF analysis in the diagnosis of LNB. Corticosteroids did not affect the recovery from FP and CSF findings had no prognostic value on recovery from FP.

Fields of Study & Subjects

Vector-borne infectious diseases Infectious Encephalopathies and Encephalitis Syphilis Diagnosis and Treatment

Publication details

Journal / source
BMC Infectious Diseases
Volume
26
Issue
1
Pages
338–338
Publication date
19 January 2026
Language
EN